Related Experiment Video
Updated: Aug 9, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
New therapies for uremic secondary hyperparathyroidism
Pablo Ureña Torres1, Dominique Prié, Laurent Beck
1Service de Néphrologie et Dialyse, Clinique de l'Orangerie, Aubervilliers, France. urena.pablo@wanadoo.fr
Secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) affects millions. Current treatments for SHPT have limitations, driving the need for novel therapeutic strategies and drug development.
Area of Science:
- Nephrology
- Endocrinology
Background:
- Secondary hyperparathyroidism (SHPT) is a prevalent complication in chronic kidney disease (CKD), impacting millions globally.
- Existing therapies for SHPT, including calcium salts, vitamin D, and phosphate binders, often present challenges like hypercalcemia and limited efficacy.
- Surgical parathyroidectomy (PTX), while effective, carries significant risks, including anesthesia complications and permanent hypoparathyroidism.
Purpose of the Study:
- To provide a comprehensive overview of emerging therapeutic strategies for managing SHPT in CKD patients.
- To highlight the limitations of traditional SHPT treatments and the imperative for developing new interventions.
Main Methods:
- Literature review of current and novel therapies for SHPT.
- Analysis of the mechanisms and potential applications of various drug classes.
Main Results:
- Identified a wide range of new therapies including vitamin D analogs, novel phosphate binders, calcimimetics, and others.
- Discussed the potential benefits and challenges associated with each therapeutic approach.
Conclusions:
- The development of novel therapies is crucial for optimizing SHPT management in CKD.
- Combination therapies may offer improved outcomes for patients with SHPT.
More Related Videos
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Urinary Tract Calculi VI: Surgical Management
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

